Publications
Specialty
Search
Rheumatology & Arthritis
06/24/2024
Researchers found distinct variations between patients with nonradiographic and radiographic axial spondyloarthritis in age of disease onset, sex, and other factors.
Podiatry Today, Podiatry
06/23/2024
Dr. DeHeer recently spoke to Podiatry Today about his session at the Western Foot and Ankle Conference.
The Dermatologist
06/23/2024
In a comprehensive analysis pooling data from 2 pivotal phase 3 trials, researchers have shown that dupilumab effectively alleviates pruritus and reduces skin lesions in patients with prurigo nodularis, irrespective of the severity of their baseline condition.
The Dermatologist
06/22/2024
In a new approach to assess long-term treatment outcomes for atopic dermatitis (AD), researchers have introduced a novel efficacy index that accounts for both on-drug and off-drug responses at Week 52.
EMSWorld
06/21/2024
Scott DeBoer sits down with EKG expert Bob Page, who shares some of his top tips and insights. Don't miss out on his invaluable advice!
Oncology
06/21/2024
Based on results from the KRYSTAL-1 trial, the FDA has granted accelerated approval to adagrasib with cetuximab for patients with KRAS G12C-mutated colorectal cancer.
The Dermatologist
06/21/2024
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Pharmacy Learning Network
06/21/2024
The Oregon Court of Appeals has recently reversed the dismissal of a case against several health care providers and Walgreens Pharmacy and remanded the case for a jury trial. The issue is particularly interesting because the plaintiff was injured by someone else who had been treated by the health care providers and the pharmacy. The plaintiff herself had no relation to the health care providers or pharmacy.
Psych Congress Network
06/21/2024
Two of the 5 characteristic symptoms of schizophrenia must be present for a diagnosis to be made. At least one of these must be which of the following, according to the DSM-5-TR? Take the quiz!
First Report Managed Care
06/21/2024
Johnson & Johnson aims to expand use of its HIV-1 therapy, Prezcobix, for younger patients in the US, potentially paving the way for improved treatment options for pediatric patients with the virus.
Wound Care
06/21/2024
GR Consulting brings senior level experience from across specialties, and provides the leadership experience, technical ingenuity, and a strong industry network to help start-up and emerging wound care companies execute the correct strategies at the right time.
Psych Congress Network, HMP Global Learning Network, Psychiatry & Behavioral Health
06/21/2024
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Oncology
06/21/2024
The FDA granted approval to imetelstat for patients with low to intermediate-1 risk MDS with transfusion-dependent anemia requiring 4 or more red blood cell transfusion units over 8 weeks, who cannot derive benefit from erythropoiesis-stimulating agents.
Oncology
06/21/2024
The FDA granted approval to blinatumomab for adult and pediatric patients with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (ALL) in the consolidation phase of multi-phase chemotherapy.
The Dermatologist
06/21/2024
In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
Advances in Inflammatory Bowel Disease Network
06/21/2024
Dr Regueiro recaps his address from Digestive Disease Week on the challenges of treating perianal and fistulizing Crohn's disease, and progress in the development of new therapies.
Oncology
06/20/2024
According to a phase 2 study, there was no difference in PFS between a combined immunotherapy regimen and a targeted therapy induction followed by combined immunotherapy among patients with BRAF/V600E/K mutant melanoma.
Oncology
06/20/2024
Erika Hamilton, MD discusses the long-term analysis from the phase 3 DESTINY-Breast03 trial which reinforced the superiority of trastuzumab deruxtecan over trastuzumab emtansine for patients with HER2-positive metastatic breast cancer previously treated with ≥1 anti-HER2 regimen.
Psych Congress Network
06/20/2024
Nishi Bhopal, MD, telehealth practitioner, providers insight into how mental health clinicians can utilize social media to improve patient outcomes and combat misinformation.
Annals of Long-Term Care, Neurology
06/20/2024
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.